Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Matthew J. Sinback

Senior Litigation Attorney

Nashville
(615) 742-7910 TEL
(615) 248-8791 FAX

Matthew J. Sinback

Senior Litigation Attorney

Nashville
(615) 742-7910 TEL
(615) 248-8791 FAX
Nashville
(615) 742-7910 TEL
(615) 248-8791 FAX

Matt Sinback's practice focuses on antitrust counseling and litigation. Matt also has experience in general business litigation, agency representation of utilities, internal investigations and human rights litigation.

  • Antitrust & Trade Practices – Matt regularly counsels clients on antitrust issues arising in significant mergers and acquisitions, including Hart-Scott-Rodino Act compliance, the exchange of sensitive information during due diligence, integration planning and preparation for potential investigation or intervention by the Federal Trade Commission or Department of Justice. Matt has provided advice on HSR Act compliance in numerous transactions, including analysis of whether premerger notification is required and preparation of the premerger notification form required by the Act. In addition, Matt has experience in assisting clients with creating or improving their antitrust compliance policies and procedures.
  • Healthcare – Matt has provided antitrust counseling to companies in the healthcare industry, including advising on antitrust compliance programs, the antitrust implications of proposed conduct and antitrust issues associated with significant mergers.
  • Administrative & Regulatory Proceedings – Matt has served on the trial counsel team in utility ratemaking proceedings before the Tennessee Regulatory Authority.

Memberships

American Bar Association — Section of Antitrust Law: Mergers & Acquisitions Committee, Compliance & Ethics Committee, Health Care and Pharmaceuticals Committee; Section of Litigation

American Health Lawyers Association (AHLA) — Antitrust Practice Group

Tennessee Bar Association

News

View More

Representative Experience

View More

Media Mentions

View More

Accolades

American Criminal Law Review — Articles and Notes Editor

Phi Beta Kappa

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.